Page 158 - Read Online

Dokko et al. Vessel Plus 2022;6:53 https://dx.doi.org/10.20517/2574-1209.2022.11 Page 13 of 15

Authors’ contributions
Substantive intellectual contribution: Dokko J, Novotny S, Kolba N, Agha S, Yaligar A, Tummala V, Parikh
PB, Pyor AD, Tannous HJ, Shroyer AL, Bilfinger T
Study conception and design: Dokko J, Novotny S, Tannous HJ, Shroyer AL, Bilfinger T
Data coding/acquisition: Dokko J, Novotny S, Kolba N, Tummala V, Agha S, Yaligar A, Parikh PB, Pryor
AD, Bilfinger T, Shroyer AL, Bilfinger T
Data analysis/interpretation: Dokko J, Shroyer AL, Bilfinger T
Writing the initial abstract/manuscript: Dokko J, Novotny S, Shroyer AL, Bilfinger T
Revising the submitted abstract/manuscript: Dokko J, Novotny S, Kolba N, Agha S, Yaligar A, Tummala V,
Parikh PB, Pryor AD, Tannous HJ, Shroyer AL, Bilfinger T
Reviewing and approving the submitted abstract/manuscript: Dokko J, Novotny S, Kolba N, Agha S, Yaligar
A, Tummala V, Parikh PB, Pryor AD, Tannous HJ, Shroyer AL, Bilfinger T

Availability of data and materials
All patient records and data were extracted from 2005-2018 SPARCS Database. Due to contractual
limitations (i.e., concerns regarding patient records being re-identified) in the Stony Brook University data
use agreement, no reports could contain cells that had lower than 10 events; thus, only percentages were
reported in [Tables 1-3].

Financial support and sponsorship
This study was supported by the Stony Brook Renaissance School of Medicine Department of Medicine
small grant (led by Dr. Puja B. Parikh and Dr. A. Laurie Shroyer) and the Division of Cardiothoracic
surgery General T.F. Cheng endowment led by Dr. Henry J. Tannous.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
This study was approved for IRB exemption under not human study research on 11/23/2021 [IRB2021-
00605: POAF r-AVR].

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Hu PP. TAVR and SAVR: current treatment of aortic stenosis. Clin Med Insights Cardiol 2012;6:125-39. DOI PubMed PMC
2. Saad AM, Kassis N, Isogai T, et al. Trends in outcomes of transcatheter and surgical aortic valve replacement in the United States
(2012-2017). Am J Cardiol 2021;141:79-85. DOI PubMed
3. Mori M, Gupta A, Wang Y, et al. Trends in transcatheter and surgical aortic valve replacement among older adults in the United
States. J Am Coll Cardiol 2021;78:2161-72. DOI PubMed
4. Bartus K, Sadowski J, Litwinowicz R, et al. Changing trends in aortic valve procedures over the past ten years-from mechanical
prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National Cardiac
Surgery Database. J Thorac Dis 2019;11:2340-9. DOI PubMed PMC
5. Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol
2020;76:2492-516. DOI PubMed
6. Björn R, Nissinen M, Lehto J, et al. Late incidence and recurrence of new-onset atrial fibrillation after isolated surgical aortic valve
replacement. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00587. DOI PubMed
7. Kostyunin AE, Yuzhalin AE, Rezvova MA, Ovcharenko EA, Glushkova TV, Kutikhin AG. Degeneration of bioprosthetic heart